Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (HIMS)

Core Viewpoint - A securities class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making false statements and failing to disclose risks related to its promotion of illegitimate versions of Wegovy, leading to a significant stock price drop after the termination of its partnership with Novo Nordisk [1][2]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals or entities that purchased Hims & Hers securities between April 29, 2025, and June 23, 2025 [1]. - The complaint alleges that Hims & Hers engaged in deceptive practices that jeopardized patient safety and risked the termination of its collaboration with Novo Nordisk [2]. Group 2: Stock Impact - Following the announcement of the termination of the partnership with Novo Nordisk on June 23, 2025, Hims & Hers' stock price fell by more than 34% [2]. Group 3: Investor Information - Investors who acquired shares of Hims & Hers are encouraged to contact the law firm Gainey McKenna & Egleston before the lead plaintiff motion deadline on August 25, 2025 [3].